My 20s, my 30s, and now my 40s would have me fighting an old battle as if life were nothing but a set of old patterns
I did NAD because I wanted to bounce back as soon as possible
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Nerelius C, Sandegren A, Sargsyan H, Raunak R, Leijonmarck H, Chatterjee U, Fisahn A, Imarisio S, Lomas DA, Crowther DC, Strmberg R (2009) -helix targeting reduces amyloid- peptide toxicity
10.3389/fcimb.2017.00244 Front Cell Infect Microbiol